Point72 Asia (Singapore)’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $203K | Buy |
11,401
+112
| +1% | +$1.99K | 0.04% | 345 |
|
|
2025
Q1 | $201K | Buy |
11,289
+4,388
| +64% | +$78.2K | 0.05% | 277 |
|
|
2024
Q4 | $206K | Buy |
6,901
+5,008
| +265% | +$149K | 0.05% | 239 |
|
|
2024
Q3 | $29.6K | Sell |
1,893
-91
| -5% | -$1.42K | 0.01% | 766 |
|
|
2024
Q2 | $34K | Buy |
+1,984
| New | +$34K | 0.01% | 745 |
|
|
2024
Q1 | – | Sell |
-5,354
| Closed | -$79.9K | – | 1179 |
|
|
2023
Q4 | $79.9K | Buy |
+5,354
| New | +$79.9K | 0.02% | 246 |
|